Find a specific notice:
Notice Type
Departmental
Notice Title

Consent to the Distribution of New Medicines

Publication Date
4 Aug 2022

Tags

Medicines Act Consent to the distribution of new medicines Health

Notice Number

2022-go3221
Title
View PDF
File Type and Size
PDF (35 KB)

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product: Levetiracetam
Active Ingredient: Levetiracetam 250mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Max Health Limited
Manufacturer: Lupin Limited, Verna, India
   
Product: Levetiracetam
Active Ingredient: Levetiracetam 500mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Max Health Limited
Manufacturer: Lupin Limited, Verna, India
   
Product: Levetiracetam
Active Ingredient: Levetiracetam 750mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Max Health Limited
Manufacturer: Lupin Limited, Verna, India
   
Product: Levetiracetam
Active Ingredient: Levetiracetam 1000mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Max Health Limited
Manufacturer: Lupin Limited, Verna, India
   
Product: Pantoprazole-AFT
Active Ingredient: Pantoprazole sodium sesquihydrate 45.1mg equivalent to pantoprazole 40mg
Dosage Form: Powder for injection
New Zealand Sponsor: AFT Pharmaceuticals Limited
Manufacturer: Hainan Poly Pharma Co. Limited, Haikou, China


Dated this 29th day of July 2022.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).